C19orf12 mutation leads to a pallido-pyramidal syndrome

Area of Science:

• Neurogenetics
• Neurodegenerative Disorders
• Molecular Biology

Background:

• Pallido-pyramidal syndromes are complex neurodegenerative disorders characterized by dystonia, parkinsonism, and spasticity.
• Several genes, including FBXO7, ATP13A2, PLA2G6, PRKN, and SPG11, are implicated in these syndromes.
• Brain iron deposition is inconsistently observed with mutations in ATP13A2 and PLA2G6.

Observation:

• A multiplex consanguineous Saudi Arabian family presented with a pallido-pyramidal syndrome, cerebellar atrophy, and brain iron deposition.
• Homozygosity mapping and direct sequencing were employed to investigate the genetic basis of the condition within this family.
• A novel homozygous mutation, p.G53R, in the C19orf12 gene was identified as the causative factor.

Findings:

• The study identified a homozygous p.G53R mutation in the C19orf12 gene in the affected family.
• This finding establishes a direct link between C19orf12 mutations and the observed complex phenotype.
• The identified mutation expands the known genotypic spectrum associated with C19orf12.

Implications:

• This discovery broadens the understanding of the genetic underpinnings of pallido-pyramidal syndromes.
• It highlights C19orf12 as a significant gene involved in neurodegeneration with potential iron accumulation.
• The findings contribute to the diagnostic landscape for patients presenting with similar neurological symptoms and brain imaging findings.